Inventor · disambiguated record
Dongxu Shu
Also filed as: SHU DONGXU
4 granted patents·8 pending applications·12 citations·filing 2015–2025
69Inventor score
Files withSHANGHAI ARGO BIOPHARMACEUTICAL CO LTD6ARROWHEAD PHARMACEUTICALS INC4WISCONSIN ALUMNI RES FOUND2
Top patents by PatentIndex Score
12 records- 0186US9969686B2Synthesis of diindolylmethanes and indolo[3,2-b]carbazoles, compounds formed thereby, and pharmaceutical compositions containing themWISCONSIN ALUMNI RES FOUND·Filed 2015·Granted May 15, 2018·6 cites·3 claims
- 0285US10730833B2Synthesis of diindolylmethanes and indolo[3,2-b]carbazoles, compounds formed thereby, and pharmaceutical compositions containing themWISCONSIN ALUMNI RES FOUND·Filed 2018·Granted Aug 4, 2020·4 cites·7 claims
- 0382US11597701B2Integrin ligands and uses thereofARROWHEAD PHARMACEUTICALS INC·Filed 2018·Granted Mar 7, 2023·2 cites·24 claims
- 0467US2024076270A1Integrin ligands and uses thereofARROWHEAD PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0565US2024084304A1Composition and method for inhibiting angiotensinogen (agt) protein expressionSHANGHAI ARGO BIOPHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0658US2025297250A1Composition and method for inhibiting expression of protein lpa(apo(a))SHANGHAI ARGO BIOPHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0755US2025257356A1Composition and method for inhibiting expression of protein lpa(apo(a))SHANGHAI ARGO BIOPHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 0853US2024376475A1Compositions and methods for inhibiting expression of angiopoietin-like 3 (angptl3) proteinSHANGHAI ARGO BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0951US12221610B2RNAi agents for inhibiting expression of HIF-2 alpha (EPAS1), compositions thereof, and methods of useARROWHEAD PHARMACEUTICALS INC·Filed 2020·Granted Feb 11, 2025·0 cites·20 claims
- 1050US2025145999A1Compositions and methods for inhibiting expression of prekallikrein (pkk) proteinSHANGHAI ARGO BIOPHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1149US2024271141A1Composition and method for inhibiting expression of hepatitis b virus (hbv)proteinSHANGHAI ARGO BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1241US2021093725A1Integrin targeting ligands and uses thereofARROWHEAD PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dongxu Shu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →